Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.05) by 120 percent. This is a 114.29 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $13.835 million which beat the analyst consensus estimate of $12.886 million by 7.36 percent. This is a 11.98 percent increase over sales of $12.355 million the same period last year.